Literature DB >> 31041060

Biomarkers of immunosuppression.

Tiong Yeng Lim1, Michael Heneghan1.   

Abstract

Year:  2016        PMID： 31041060      PMCID： PMC6490196          DOI： 10.1002/cld.570

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  3 in total

Review 1.  SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression.

Authors:  Jairo Cajamarca-Baron; Diana Guavita-Navarro; Jhon Buitrago-Bohorquez; Laura Gallego-Cardona; Angela Navas; Hector Cubides; Ana María Arredondo; Alejandro Escobar; Adriana Rojas-Villarraga
Journal:  Reumatol Clin (Engl Ed)       Date:  2020-09-11

Review 2.  Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis.

Authors:  Axel Nierhaus; Giorgio Berlot; Detlef Kindgen-Milles; Eckhard Müller; Massimo Girardis
Journal:  Ann Intensive Care       Date:  2020-10-07       Impact factor: 6.925

Review 3.  [SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression].

Authors:  Jairo Cajamarca-Baron; Diana Guavita-Navarro; Jhon Buitrago-Bohorquez; Laura Gallego-Cardona; Angela Navas; Hector Cubides; Ana María Arredondo; Alejandro Escobar; Adriana Rojas-Villarraga
Journal:  Reumatol Clin       Date:  2020-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.